Bradley & Co. Private Wealth Management LLC Acquires New Holdings in Colgate-Palmolive (NYSE:CL)

Bradley & Co. Private Wealth Management LLC bought a new stake in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 846 shares of the company’s stock, valued at approximately $77,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Swedbank AB boosted its stake in shares of Colgate-Palmolive by 1.4% during the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after acquiring an additional 40,324 shares during the last quarter. NorthCrest Asset Manangement LLC purchased a new position in Colgate-Palmolive in the 3rd quarter valued at about $208,000. J.W. Cole Advisors Inc. boosted its stake in shares of Colgate-Palmolive by 40.0% during the 3rd quarter. J.W. Cole Advisors Inc. now owns 15,311 shares of the company’s stock worth $1,590,000 after purchasing an additional 4,378 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Colgate-Palmolive by 1.0% during the third quarter. Nisa Investment Advisors LLC now owns 240,511 shares of the company’s stock worth $24,967,000 after buying an additional 2,350 shares in the last quarter. Finally, Fidelis Capital Partners LLC raised its position in shares of Colgate-Palmolive by 9.3% in the third quarter. Fidelis Capital Partners LLC now owns 13,812 shares of the company’s stock valued at $1,367,000 after buying an additional 1,173 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL opened at $92.36 on Wednesday. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The firm has a market cap of $74.95 billion, a price-to-earnings ratio of 26.24, a PEG ratio of 4.20 and a beta of 0.44. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a fifty day simple moving average of $88.86 and a 200 day simple moving average of $95.66.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. Equities research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.

Wall Street Analysts Forecast Growth

CL has been the subject of several analyst reports. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. Raymond James restated an “outperform” rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.